<DOC>
	<DOCNO>NCT02066805</DOCNO>
	<brief_summary>This study aim evaluate off-label XGEVA use Denmark use data link registry source Northern Jutland Region Copenhagen . This allow accurate assessment prescription diagnose , especially related cancer patient first year post initial market availability XGEVA .</brief_summary>
	<brief_title>Estimation Off-Label Use XGEVA® ( Denosumab ) Using Population-Based Databases Denmark</brief_title>
	<detailed_description />
	<mesh_term>Denosumab</mesh_term>
	<criteria>The study include patient prescription XGEVA® give secondary care minimum 108 XGEVA user , Northern Jutland Region Copenhagen first 1year post XGEVA market availability , define 12 month RADS opinion 24th January 2013 minimum sample achieve .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>